Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Dec 24, 2024, 3:00 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $12.02 million as of December 27, 2024. Its market cap has decreased by -28.16% in one year.
Market Cap
12.02M
Enterprise Value
24.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 12.02M, an increase of 31.41%. That is a compound annual growth rate of 4.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 24, 2024 | 10.96M | -28.25% |
Dec 29, 2023 | 15.27M | -13.24% |
Dec 30, 2022 | 17.60M | -71.94% |
Dec 31, 2021 | 62.72M | 225.64% |
Dec 31, 2020 | 19.26M | 34.48% |
Dec 31, 2019 | 14.32M | 56.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 18.07B |
Telix Pharmaceuticals Limited | 5.22B |
Elekta AB (publ) | 2.09B |
Ryman Healthcare Limited | 1.72B |
Verano Holdings Corp. | 463.76M |
Vireo Growth Inc. | 129.65M |
Medexus Pharmaceuticals Inc. | 55.68M |